Ipsen CEO sees China returning to normal
This article was originally published in Scrip
Executive Summary
Marc de Garidel, chairman and CEO of French firm Ipsen, is seeing a return to business as usual in the Chinese hospital market following a hit to the drug sales of multinational pharma companies there in connection with the high-profile investigations into companies including GlaxoSmithKline.